Impilo, Amalungiselelo
'Coraxan' imithi. Yokusetshenziswa
On the ukulungiselela "Coraxan" kukhona izimpendulo ezahlukene. Ezinye iziguli abe ngempumelelo okuphawulekayo umkhiqizo. Abanye kokuthola imithi kubangela imiphumela eminingi engemihle njengezindlela kuphela. Lithi bonke abantu babe bezibona eyodwa noma esinye isidakamizwa lihlukile. Ukuze ugweme ukuthuthukiswa yimuphi nemiphumela ebuhlungu ngaphambi kokusebenzisa imithi kuyadingeka hhayi kuphela ukufunda isifinyezo, kodwa futhi uye kudokotela uyofuna icebiso.
Nomuthi "Coraxan" iza ngesimo amaphilisi, camera elikhanyayo orange jacket. Kolunye uhlangothi kule mpi ulotshwe inkampani logo. Olunye uhlangothi tablet iqukethe inombolo "5" (Ukulungiselela "Coraxan 5") noma "7.5". ingxenye Active - hydrochloride ivabradine.
Kusho imiyalelo "Coraxan" ukusetshenziswa libhekisela eqenjini izidakamizwa antianginal. Lo mshini wezenzo kusekelwe izidakamizwa ethize kanye okusithiyayo ukukhetha iziteshi elawula ukusikwa ukushaya kwenhliziyo depolarization diastolic (nokuguqulwa).
I asebenzayo izidakamizwa izidakamizwa akunamthelela le intracardiac conductivity ventricular repolarization noma contractility.
Nomuthi "Coraxan" imfundo manual uncoma ekwelapheni esitebeleni angina pectoris nge evamile itheku isigqi in iziguli Izimo noma ukungabekezelelani ukuze beta-blocker.
Umuthi esithathwayo yesidlo, ngaphakathi.
Ngokuvamile, umthamo kokuqala kuchaza angu eziyishumi ngosuku (ithebhulethi (angu emihlanu) kabili ngelanga). Ngokuhambisana kusebenta zokwelapha emva ezintathu kuya amane amasonto imithi ukusetshenziswa is kuvunyelwe okwandisa umthamo kuya ku-15 mg (e 7.5 mg ithebhulethi kabili ngosuku).
With ukuthuthukiswa izimpawu bradycardia (hypotension, isiyezi, ukukhathala), noma nge ukwehla kwenhliziyo amazinga amabhithi esingaphansi amahlanu ngomzuzu kufanele usethe umthamo ephansi. Uma emva ukulungisa izibalo musa ukushintsha, izidakamizwa amankeyane.
Iziguli kwasebekhulile (abaneminyaka engaphezu kuka ayisikhombisa) kadokotela "Coraxan" imfundo manual incoma sithome umthamo angu amabili kuya polovonoy (poltabletki angu emihlanu) kabili ngelanga. Ngokuhambisana ngezimo zesiguli kungenzeka kancane kancane ukwandisa umthamo kwalokho.
Imithi kungadala ezinye abantu basabele ngendlela embi. Ngu imiphumela emibi lesi sidakamizwa "Coraxan" yokusetshenziswa libhekisela lo mkhuba izinguquko photoreception (photopsia), bradycardia, vimba atrioventricular, arrhythmias (supraventricular), palpitations. Liphinde Cishe eziya ziba zimbi ka angina, ukuthuthukiswa ventricular tachycardia, isilethikusebenza, fibrillation atrial. Ukusetshenziswa kwezidakamizwa kungabangela sohudo, ikhanda, ukuqunjelwa, imisipha amajaqamba, isicanucanu, iphika, eosinophilia, isiyezi.
ejenti contraindicated "Coraxan" lapho ukuvinjelwa sinoatrial, esivimba amanzi acute, ukushaqeka cardiogenic, kwenhliziyo esingaphansi amabhithi ayisithupha ngomzuzu lapho esephumule, ukwehluleka ezinzima isibindi. Musa akunikeze imithi ngoba engazinzile angina pectoris, block atrioventricular ngowesithathu, izithole besigaba sesibili. ukulungiselela ezinconyiwe "Coraxan" ngesikhathi sokukhulelwa. Uma kunesidingo, sebenzisa imithi ngesikhathi lactation yokudla imisiwe.
Imithi akuyona aphumelele nokwelashwa arrhythmias inhliziyo. Isenzo zomuthi kuyehla isizinda tachyarrhythmias.
Kusho hhayi Kunconywa for iziguli fibrillation atrial nezinye arrhythmia elihlobene ne-umsebenzi itheku engeyokuqala.
Ngaphambi ukuqokwa izidakamizwa idingekile ukuze Ukuhlola nesiguli khona yinhliziyo (Yiqiniso zezifo ezingelapheki).
Similar articles
Trending Now